| Literature DB >> 11746050 |
J L Johnson1, K E Coyne, K V Rajagopalan, J L Van Hove, M Mackay, J Pitt, A Boneh.
Abstract
Molybdenum cofactor deficiency is a rare inborn error of metabolism with generally severe symptoms, most often including neonatal seizures and severe developmental delay. We describe a patient with an unusually mild form of the disease. Two mutations in MOCS2A (molybdenum cofactor synthesis enzyme 2A) were identified: a single base change, 16C > T, that predicts a Q6X substitution on one allele and a 19G > T transversion that predicts a valine to phenylalanine substitution, V7F, on the second. It is postulated that the milder clinical symptoms result from a low level of residual molybdopterin synthase activity derived from the 19G > T allele. Copyright 2001 Wiley-Liss, Inc.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11746050 DOI: 10.1002/1096-8628(20011122)104:2<169::aid-ajmg1603>3.0.co;2-8
Source DB: PubMed Journal: Am J Med Genet ISSN: 0148-7299